chrisvoncsefalvay/vaers-outcomes huggingface dataset:
after I received the 2nd booster: Very cold, severe body jerks, sharp pains throughout my body; After I received the 2nd booster: Very cold, severe body jerks, sharp pains throughout my body; After I received the 2nd booster: Very cold, severe body jerks, sharp pains throughout my body; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Sep2022 at 18:15 as dose 4 (booster), single (Lot number: GJ2524) at the age of 65 years, in left arm for covid-19 immunisation; influenza vaccine inact split 4v (FLUZONE HIGH DOSE QUADRIVALENT), on 22Sep2022 as dose 1, single (Lot number: UJ924AB), in right arm for immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: TRIAMTERENE HCTZ. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; Unknown manufacturer), for COVID-19 Immunization; Covid-19 vaccine (1st Booster), for COVID-19 Immunization. The following information was reported: DYSKINESIA (non-serious), PAIN (non-serious) all with onset 22Sep2022 at 17:30, outcome "recovering" and all described as "After I received the 2nd booster: Very cold, severe body jerks, sharp pains throughout my body"; FEELING COLD (non-serious) with onset 22Sep2022 at 17:30, outcome "recovering", described as "after I received the 2nd booster: Very cold, severe body jerks, sharp pains throughout my body". Therapeutic measures were not taken as a result of feeling cold, dyskinesia, pain.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. These effects occurred Thursday, 22Sep2022, at 5:30 pm, the day after patient received the 2nd booster: Very cold, severe body jerks, sharp pains throughout my body.
I came home from work and as I got out of my car to go in the house both my hands and both my feet simultaneously went numb and started tingling. After 3 days of the symptoms not going away I went to the emergency room and clinic. After a spinal tap at a series of blood test it was suspected that I had GBS. I was sent home only for the symptoms to get worse and I went back to emergency and stayed for 5 days only to leave worth the same painful uncomfortable symptoms.
Swollen joint; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Swollen joint) and FATIGUE (Fatigue) in an adult female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis.   On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form and UPADACITINIB (RINVOQ) (Oral) at an unspecified dose. On an unknown date, the patient experienced JOINT SWELLING (Swollen joint) and FATIGUE (Fatigue). At the time of the report, JOINT SWELLING (Swollen joint) was resolving and FATIGUE (Fatigue) had resolved. The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Patient had reported that swollen joints in hands and knees. Patient was extremely fatigue after a covid. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Treatment information was not provided.
Per the patient's mother she received her 6-month vaccines yesterday.  Patient's mother stated that she noticed a fever at 4:00 in the morning.  Patient was last medicated with Tylenol at 430 this morning.  Patient's mother stated that they went to the primary care but was sent to the ER.  Patient's mother stated that she had an episode of shaking.  But it did not look like seizure activity.  Patient's mother stated that she had the same reaction the last time she got vaccines.
Patient had 2 Moderna shot, never got the booster, and had COVID.; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Jun-2022 and was forwarded to Moderna on 07-Jun-2022.    This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Patient had 2 Moderna shot, never got the booster, and had COVID.) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Patient had 2 Moderna shot, never got the booster, and had COVID.). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) at an unspecified dose and frequency. At the time of the report, COVID-19 (Patient had 2 Moderna shot, never got the booster, and had COVID.) outcome was unknown.            No concomitant medication information was provided.   On an unknown date, the patient received unspecified medication as a co-suspect product (unknown route) at an unspecified dose with unknown batch number, and action taken was given as (unknown). COMPANY COMMENT: This is an spontaneous case concerning an unknown-year-old female patient with medical history of PAXLOVID treatment at an unspecified dose and frequency who experienced the unexpected  AESI event of COVID-19 unknown days after  1st. dose of  mRNA-1273 vaccine. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   Reporter did not allow further contact; Sender's Comments: COMPANY COMMENT: This is an spontaneous case concerning an unknown-year-old female patient with medical history of PAXLOVID treatment at an unspecified dose and frequency who experienced the unexpected  AESI event of COVID-19 unknown days after  1st. dose of  mRNA-1273 vaccine. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Swollen lips. Upper lip left side only, lower lip, whole lip swollen  I took 2 Benadryl
After vaccine given began having a rapid heart rate and felt dizzy. Taken to Emergency Department and received IVF and was later discharged.
Sore shoulders; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Sore shoulders) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Sore shoulders). At the time of the report, ARTHRALGIA (Sore shoulders) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-069622, MOD-2021-069962, MOD-2021-069954 (Patient Link).   Reporter did not allow further contact
Subsequent to receiving varicella virus vaccine live the pt experienced pox at the injection site. The pt sought unspecified medical treatment. Additional information has been requested. Further information has been requested.
Pt received varicella vaccine on 5/6/99. Has now as of 5/20/05 been dx with chickenpox by Dr. Also Dx with strep infection on 5/19/05.
This spontaneous report as received from a physician refers to a patient of unknown age. In December 2012, the patient was vaccinated (route not provided) with ZOSTAVAX 19400PFU (lot number and expiry date not provided). IN December 2012, the patient may have inadvertently been administered 2 doses of ZOSTAVAX and no adverse effects reports were unknown. The action taken with ZOSTAVAX was not provided. Additional information has been requested.
Contracted COVID which lasted 2 weeks.; Redness; Swelling; Tenderness; Tightness; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tenderness), MUSCLE TIGHTNESS (Tightness), COVID-19 (Contracted COVID which lasted 2 weeks.), ERYTHEMA (Redness) and SWELLING (Swelling) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced TENDERNESS (Tenderness), MUSCLE TIGHTNESS (Tightness), ERYTHEMA (Redness) and SWELLING (Swelling). On 22-Mar-2021, the patient experienced COVID-19 (Contracted COVID which lasted 2 weeks.). At the time of the report, TENDERNESS (Tenderness), MUSCLE TIGHTNESS (Tightness), COVID-19 (Contracted COVID which lasted 2 weeks.), ERYTHEMA (Redness) and SWELLING (Swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment details include Ibuprofen and Tylenol for fever and also icepacks.   This case was linked to MOD-2021-079276 (Patient Link).
Had normal side effects for 24 hrs after vaccine(pain, chills, headache, tiredness). 2 days after vaccine, starting with significant runny nose, mild cough, mild sore throat, and some mild chest discomfort during physical activity.
Swelling, redness, pruritus at injection site on 8/17/10, but no anaphylactoid type reaction. 8/18/10 swelling increased to 3" in diameter and became "hard knot", redness reported increased from elbow to shoulder. 8/19/10 patient seen by Dr second day and was informed to have "full blown shingles". No lesion or rash were reported. Patient using ice, TYLENOL and BENADRYL for relief.
Cellulitis - patient had pneumonia and flu vaccine on October 7, 2015. Patient noticed swelling and pain around injection site, patient did not take any otc for pain. Improved with Keflex 4 TIMES DAILY, day 3/7 antibiotic. Had fever x 1 day 3 days ago none since.
Pt's symptoms started 01/01/2021. Started with LUQ pain. Her symptoms progressed 01/04/2021. Developed SOB,. fatigue, aches. She went to the LMH ER that day. Imaging showed pneumonia and PE. Started on Elliquis, referred to Hematology.
I experienced a headache, chest pain, and within 5 minutes of vaccination I also had heart palpitations. Felt weak, shaky, and pain in left carotid and headache on the left side. 30 minutes into it I had very severe pain behind my left eye, and then that went away after 2 minutes. I lost my voice, spasms in my vocal cords/throat, abdominal pain also developed. 1 hour after vaccination I experienced VTAC, weakness, my head hurt the whole time, and chest pains were coming and going. I also had very severe abdominal pain. Felt recovered after 24 hours.
Little chills; A little fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54 year-old male patient received bnt162b2 (BNT162B2), administered in deltoid left, administration date 12Aug2021 11:00 (Lot number: FA7484) at the age of 54 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Sinus issues" (ongoing), notes: Sinus issues began about 6 years ago. when he gets a cold he gets bronchitis.; "Cold" (unspecified if ongoing); "bronchitis" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Flu vaccine, for Flu immunization, reaction(s): "No adverse event". The following information was reported: CHILLS (non-serious) with onset 13Aug2021, outcome "unknown", described as "Little chills"; PYREXIA (non-serious) with onset 13Aug2021, outcome "unknown", described as "A little fever". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: The caller was a consumer reporting he received the first dose Pfizer Covid 19 Vaccine yesterday, 12Aug2021. The caller works at the county jail. The caller woke up this morning with a little chills and got a little fever, just the fever and chills every now and then. The caller knows to drink a lot of fluids. The chills happen once in a blue moon, a little if not a lot. A little fever: The caller states he took his temperature with a thermometer and it was 101. The caller took his temperature again at the jail he works at and the temperature was 97.5. The caller states the thermometer initial temperature was taken with was where you place the thermometer under the tongue. The thermometer used at the caller's workplace was a forehead thermometer. Any AE(s) did not require a visit to Emergency Room and Physician Office. Prior Vaccinations (within 4 weeks) was no AE(s) following prior vaccinations was No, because the caller has received a flu vaccine and had no symptoms at all. The caller states having symptoms after receiving the first dose Pfizer Covid Vaccine is a first for the caller. The caller will call his doctor because the doctor is out at the hospital. The caller states the sinus issues began about 6 years ago. The caller states when he gets a cold he gets bronchitis.  No follow-up attempts are possible. No further information is expected.
coughing; crying; broke out in hives; This spontaneous report was received from a nurse and refers to a 4 month old male patient with prophylaxis. His concomitant therapies included pneumococcal 4 6b 9v 14 18c 19f 23f conj vaccine (crm197) (PREVNAR), hib conj vaccine (tet toxoid), diphtheria toxoid, pertussis acellular 5-component vaccine, poliovirus vaccine inactivated (mrc-5), tetanus toxoid (PENTACEL) and omeprazole. The patient had no previous drug reactions or allergies. No information regarding the patient's medical history and concurrent conditions was reported.   On 25-JUN-2020, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) dose 1, 2 milliliter orally, lot number 1660974 was verified to be valid, expiration date reported and validated as 20-APR-2021 for prophylaxis. On 26-AUG-2020, the patient was vaccinated with the second dose of  rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 2 milliliter orally, lot number 1660974 was verified to be valid, expiration date reported and validated as 20-APR-2021 for prophylaxis.  On the same day, the patient started to cough, cry and broke out in hives. The patient was taken to an emergency room. There was no laboratory diagnostics or studies performed. It was reported that the therapy with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) was not discontinued. The outcome of the events was unknown.  The causality assessment between the events and rotavirus vaccine, live, oral, pentavalent(ROTATEQ) was not provided.  The reporter considered the events of urticaria, cough and crying to be medically significant.
Nausea, headache, vomiting, dizziness, fever (102.1), chills, body aches, rash
Incorrectly administered subcutaneously! Severe redness, swelling, pain, which continued to worsen for three days.
This spontaneous report was received from a certified medical assistant concerning an unspecified number of patients of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On an unknown date the patients were vaccinated with improperly stored doses GARDASIL (lot # K010215, expiration date 05-MAY-2017) (lot # K011325, expiration date 08-APR-2017) (route, dose and dose number were unspecified). No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
This case was reported by a nurse via sales rep and described the occurrence of nausea in a patient who received BEXSERO. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, an unknown time after receiving BEXSERO, the patient experienced nausea, influenza-like symptoms, vomiting and fever. On an unknown date, the outcome of the nausea,  influenza-like symptoms, vomiting and fever were recovering/resolving. The reporter considered the nausea, influenza-like symptoms, vomiting and fever to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the patient was administered BEXSERO and experienced nausea, fever and flu-like symptoms. The reporter was not certain about vomiting experience. The reporter felt the symptoms that were experienced by the patient were excessive. The reporter was contacted again but no information was obtained.
Patient received monovalent Pfizer on 11/4/2022 and then received bivalent Pfizer booster on 11/28/2022.  Did not complete the full primary series before receiving the booster dose.
An adult patient received her first dose of the Moderna COVID-19 vaccine.  Approximately 20 minutes later she felt dizzy and nauseated.  I spoke with her and checked her blood pressure which was elevated at 150/100.  She sat down and rested for a while and eventually decided to go home.  She stated that she might be having a panic attack as she has anxiety around vaccines.
"pain" in the upper lungs and pleuritic chest pain 1 day after his covid-19 vaccine.  Patient was seen at Hospital where an ekg  and chest x-ray were performed and were reported as normal.   Patient was seen at our office on August 13, 2021.  lung Functions were down, patient was restarted on Advair 250/50 1 puff twice daily.  A d-dimer was negative.
covid-19; covid-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Mar2021 as dose 1, single (Lot number: EP6955), in left arm, on 25Apr2021 as dose 2, single (Lot number: ER8735), in right arm and on 07Dec2021 as dose 3 (booster), single (Lot number: FH8030) at the age of 64 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing); "Sulfa allergy" (unspecified if ongoing), notes: Known allergy: Sulfa. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "covid-19". Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Patient did not taking any other medications/products within 2 weeks of starting COVID-19 treatment. Covid rebound 3 days after ending Paxlovid with recurring symptoms and testing positive 6 days after.
Patient got Shingrix on 9-18-2020. Four days after shingrix shot on 9-21-20, patient noticed a rash on the corner of the mouth that extended between the nose and lips. No rash on the lips, and no other symptoms reported. He described the rash had blisters with burning sensation. A pain scale (1-10) with a grading of 4 to him. On 9-26-20, he reported the symptoms to pharmacy. He noted the rash got better and it is currently peeling. He was advised to see his primary doctor, which he said he will if he finds the symptoms worsening.
Information was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Medical history, concurrent conditions, and concomitant medications were not provided. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2014, a pharmacist, at a pharmacy, administered the ZOSTAVAX (lot number, dosage and route of administration not provided) to the patient. On or about 12-OCT-2016, the patient was treated by her healthcare provider (an unspecified healthcare professional) at a medical center for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
headache,hard breath. patient c/o chills, headache when waking this morning. states recieved the J&J covid vaccine yesterday. denies N/V/D. HPI:19-year-old male with chief complaint of headache nausea and body aches.  Symptoms started this morning.  He received his J&J vaccine yesterday.  He has not taken anything for the symptoms.  He denies any vomiting and nausea is improving.
I got my Pfizer booster on 11/7/2021, and early in December 2021, I started having eye pain and severe light sensitivity in the right eye, which resulted in my visiting the local emergency room on 12/11/2021. They gave me ointment for conjunctivitis and referred me to an eye doctor at the eye care center. The eye doctor started me on steroid eye drops. My condition didn't get better, and I probably visited the eye doctor every week in December. They eventually diagnosed me with Uveitis, and they gave me a round of steroid eye drops. I had three rounds, and every time a round was completed, I had rebound symptoms. My last round was completed 3/17/2022. After I got off the steroids, I took Ibuprofen at least once a day to manage the pain. In April 2022, I was referred to a doctor. The doctor diagnosed me with Shingles, and she gave me a 14-day course of Valtrex, steroid eye drops and Celebrex. I also experienced increased pressure in the right eye, and I took Timolol eye drops to treat it. I completed the therapy on 5/6/2022. I felt fine for one day, but I started to have pain in the right eye again on 5/8/2022. I started taking Celebrex again. I left a message for the doctor to inform her of the situation, and at the time of this writing, I have not yet heard back from her. I have a follow-up appointment on 5/24/2022. I am still having discomfort in the right eye, though it's not as severe.
5 weeks pregnant swollen lymph node, golf-ball sized on collar bone, same side as injection. Warm to the touch and moveable, agitated by pressure and palpation.
Employee complained of a runny nose and itchy eyes about 15 minutes after receiving vaccine.  Then her ears and throat began itching.  Skin around her eyes became red.  37.5 mg of Benadryl po given.  She went home that afternoon and took her allegra and singulair.  She states around 2 pm the itchy eys and ears returned and she took more Benadryl.  She states she continued taking Benadryl through Sunday when symptoms would return; states her eyes remained red and blotchy until Sunday.  Today, Monday 11/16/2009 she states she is back to normal with no residual effects.